CDH3 and breast cancer: The objective of this study was to evaluate the expression of basal biomarkers such as p63, p-cadherin and CK5, as well as estrogen receptor (ER) and Human Epidermal Receptor Growth Factor 2 (HER2), in a series of familial breast cancer cases, using tissue microarray technology (TMA).